Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers

Immune checkpoint inhibitors have transformed the management of advanced cancers, but biomarkers for the prediction of therapeutic responses have not been fully uncovered. Here, we provide a step-by-step approach for the identification of novel biomarkers from public transcriptomic datasets. We comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Jie, Cai, Yun, Xu, Rui, Zhu, Yichao, Zhao, Xinyuan, Zhang, Yan, Mao, Wenjun, Xu, Junying, Yin, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173013/
https://www.ncbi.nlm.nih.gov/pubmed/37119142
http://dx.doi.org/10.1016/j.xpro.2023.102258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173013/
https://www.ncbi.nlm.nih.gov/pubmed/37119142
http://dx.doi.org/10.1016/j.xpro.2023.102258

Ejemplares similares